Insight Into The Exercise Training Role In Preventing And Managing Non-Alcoholic Fatty Liver Disease

被引:0
|
作者
Abdelbasset, Walid Kamal [1 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Dept Hlth & Rehabil Sci, Coll Appl Med Sci, Al Kharj, Saudi Arabia
关键词
exercise training; hepatic fat; high-intensity interval; moderate-intensity; NAFLD; LIFE-STYLE MODIFICATION; PHYSICAL-ACTIVITY; HEPATIC STEATOSIS; WEIGHT-LOSS; RESISTANCE;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a major public health issue worldwide, where the economy is rising and people's lifestyles are changing rapidly. Those with NAFLD have fat deposits accumulation in their hepatocytes that are caused by factors other than alcohol and liver injury, such as obesity, diabetes, and metabolic disorders. To demonstrate comprehensive and technical references for prescribing exercise programs for NAFLD treatment, we have proposed this review to clarify the role of exercise in the management and prevention of NAFLD using several previous studies investigating the clinical efficiency of various therapeutic exercise modalities in NAFLD patients. Endurance and strengthening training should be done twice a week at least and ideally three times a week, with at least eight exercises targeting the groups of major muscles with a repetition of 10-15 times each exercise at a moderate to high intensity, according to universal commendations of 150 minutes a week moderate-intensity aerobic exercises. In addition, patients who are unable to participate in formal exercise programs should aim to reduce or break up their sedentary time by a few minutes of walking. Patients' exercise compliance and achievement of exercise goals should be closely monitored to ensure therapeutic effects.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [42] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [43] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
  • [44] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [45] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [46] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15
  • [47] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [48] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [49] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [50] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Zhang, Chunye
    Liu, Shuai
    Yang, Ming
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161